Company Analysis China Pioneer Pharma Holdings Ltd
1. Summary
Advantages
- Dividends (3.6%) are higher than the sector average (0%).
- The stock's return over the last year (7.14%) is higher than the sector average (-26.37%).
Disadvantages
- Price (2.07 HK$) is higher than fair price (1.96 HK$)
- The company's current efficiency (ROE=0%) is lower than the sector average (ROE=0%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| China Pioneer Pharma Holdings Ltd | Index | ||
|---|---|---|---|
| 7 days | 1.6% | 2.9% | -1.3% |
| 90 days | -5.3% | -32.1% | 8% |
| 1 year | 7.1% | -26.4% | 19.5% |
1345 vs Sector: China Pioneer Pharma Holdings Ltd has outperformed the "" sector by 33.51% over the past year.
1345 vs Market: China Pioneer Pharma Holdings Ltd has significantly underperformed the market by -12.34% over the past year.
Stable price: 1345 is not significantly more volatile than the rest of the market on "Hong Kong Exchanges" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 1345 with weekly volatility of 0.1374% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (2.07 HK$) is higher than the fair price (1.96 HK$).
Price is higher than fair: The current price (2.07 HK$) is 5.3% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is higher than that of the sector as a whole (0).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (26.67).
4.3. P/BV
P/BV vs Sector: The company's P/BV (0) is higher than that of the sector as a whole (0).
P/BV vs Market: The company's P/BV (0) is higher than that of the market as a whole (-11.94).
4.4. P/S
P/S vs Sector: The company's P/S indicator (0) is higher than that of the sector as a whole (0).
P/S vs Market: The company's P/S indicator (0) is lower than that of the market as a whole (2.77).
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (0) is higher than that of the sector as a whole (0).
EV/Ebitda vs Market: The company's EV/Ebitda (0) is lower than that of the market as a whole (9.94).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -20% over the last 5 years.
Earnings Slowdown: The last year's return (-100%) is below the 5-year average return (-20%).
Profitability vs Sector: The return for the last year (-100%) is lower than the return for the sector (0%).
5.4. ROE
ROE vs Sector: The company's ROE (0%) is lower than that of the sector as a whole (0%).
ROE vs Market: The company's ROE (0%) is lower than that of the market as a whole (6.3%).
5.5. ROA
ROA vs Sector: The company's ROA (0%) is lower than that of the sector as a whole (0%).
ROA vs Market: The company's ROA (0%) is lower than that of the market as a whole (3.39%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 3.6% is higher than the average for the sector '0%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 3.6% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 3.6% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
